Information Provided By:
Fly News Breaks for August 13, 2018
EVHC
Aug 13, 2018 | 06:51 EDT
Cantor Fitzgerald analyst Joseph France raised his price target for Envision Healthcare to $46 to reflect KKR's pending acquisition. The analyst notes the $9.9B deal is expected to close in Q4 and represents a multiple of 10 times his 2018 adjusted EBITDA estimate. France reiterates a Neutral rating on Envision Healthcare.
News For EVHC From the Last 2 Days
There are no results for your query EVHC